Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTSH
2476
DELISTED
Tile Shop Holdings
TTSH
| $762K | ﹤0.01% |
110,000
+27,200
| +33% | +$182K |
|
2477
Lifestance Health
LFST
$4B
| $761K | ﹤0.01% |
155,000
-105,700
| -41% | -$637K |
|
2478
Coffee Holding Co
JVA
$19.5M
| $759K | ﹤0.01% |
324,564
+8,900
| +3% | +$13.6K |
|
2479
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
| $758K | ﹤0.01% |
5,900
+3,900
| +195% | +$499K |
|
|
CLSD
2480
DELISTED
Clearside Biomedical
CLSD
| $757K | ﹤0.01% |
38,846
+2,393
| +7% | +$46.2K |
|
2481
ThredUp
TDUP
$746M
| $756K | ﹤0.01% |
444,412
+91,708
| +26% | +$167K |
|
2482
Assembly Biosciences
ASMB
$498M
| $753K | ﹤0.01% |
54,911
+15,451
| +39% | +$220K |
|
2483
Ponce Financial Group
PDLB
$488M
| $753K | ﹤0.01% |
82,394
-1,500
| -2% | -$13K |
|
|
TAIT
2484
DELISTED
Taitron Components
TAIT
| $751K | ﹤0.01% |
283,546
-17,227
| -6% | -$51.6K |
|
2485
V2X
VVX
$2.83B
| $748K | ﹤0.01% |
15,600
-4,600
| -23% | -$218K |
|
|
IGMS
2486
DELISTED
IGM Biosciences
IGMS
| $747K | ﹤0.01% |
108,693
+60,593
| +126% | +$518K |
|
2487
PLAYSTUDIOS Inc
MYPS
$77.9M
| $745K | ﹤0.01% |
360,000
+63,800
| +22% | +$150K |
|
2488
Orthofix Medical
OFIX
$477M
| $744K | ﹤0.01% |
56,071
-61,465
| -52% | -$842K |
|
|
SLN
2489
Silence Therapeutics
SLN
$495M
| $743K | ﹤0.01% |
39,100
-64,800
| -62% | -$1.38M |
|
2490
Wipro
WIT
$19.6B
| $737K | ﹤0.01% |
+241,800
| New | +$666K |
|
2491
NextCure
NXTC
$16.9M
| $735K | ﹤0.01% |
38,512
+5,145
| +15% | +$100K |
|
|
SNCR
2492
DELISTED
Synchronoss Technologies
SNCR
| $734K | ﹤0.01% |
78,974
+6,700
| +9% | +$54.5K |
|
2493
Nortech Systems
NSYS
$37.8M
| $734K | ﹤0.01% |
53,799
+3,540
| +7% | +$49.8K |
|
|
CODX
2494
Co-Diagnostics
CODX
$5.31M
| $734K | ﹤0.01% |
19,567
-446
| -2% | -$16.2K |
|
2495
iShares MSCI Taiwan ETF
EWT
$10.2B
| $732K | ﹤0.01% |
13,500
-13,200
| -49% | -$661K |
|
|
NXDT
2496
NexPoint Diversified Real Estate Trust
NXDT
$234M
| $730K | ﹤0.01% |
+132,063
| New | +$753K |
|
|
VBTX
2497
DELISTED
Veritex Holdings
VBTX
| $730K | ﹤0.01% |
+34,623
| New | +$700K |
|
|
MURA
2498
DELISTED
Mural Oncology
MURA
| $729K | ﹤0.01% |
232,100
+15,100
| +7% | +$55.7K |
|
2499
Simplify Interest Rate Hedge ETF
PFIX
$184M
| $727K | ﹤0.01% |
15,200
-2,200
| -13% | -$108K |
|
|
MRNS
2500
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $727K | ﹤0.01% |
+621,625
| New | +$1.56M |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.